|[February 05, 2014]
Foundation Medicine to Present at the 2014 Leerink Global Healthcare Conference
CAMBRIDGE, Mass. --(Business Wire)--
Medicine, Inc. (NASDAQ:FMI) today announced that Michael J. Pellini,
M.D., president and chief executive officer, is scheduled to present at
the 2014 Leerink Global Healthcare Conference on Wednesday, February 12,
2014 at 1:25 p.m. ET in New York City.
A live, listen-only webcast of the presentation can be accessed by
visiting the investors section of the Foundation Medicine website at
investors.foundationmedicine.com. A replay of the webcast will be
available shortly after the conclusion of the presentation and archived
on the company's website for two weeks following the presentation.
About Foundation Medicine
Medicine® (NASDAQ: FMI) is a molecular information
company dedicated to a transformation in cancer care in which treatment
is informed by a deep understanding of the genomic changes that
contribute to each patient's unique cancer. The company's clinical
for solid tumors and FoundationOneTM
Heme for hematologic malignancies, sarcomas and pediatric cancers, each
provide a fully informative genomic profile to identify the molecular
alterations in a patient's tumor and match them with relevant targeted
therapies and clinical trials. Foundation Medicine's molecular
information platform aims to improve day-to-day care for patients by
serving the needs of clinicians, academic researchers and drug
developers to help advance the science of molecular medicine in cancer.
For more information, please visit www.FoundationMedicine.com
or follow Foundation Medicine on Twitter
Foundation Medicine® is a registered trademark, and FoundationOneTM
is a trademark, of Foundation Medicine, Inc.
[ Back To TMCnet.com's Homepage ]